Bojoga Andreea, Stănescu Laura, Badiu Corin
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
Arch Clin Cases. 2021 Dec 29;8(4):84-90. doi: 10.22551/2021.33.0804.10191. eCollection 2021.
Thyroid collision tumors are rare entities that designate two histologically and morphologically distinct tumors that occur simultaneously or as metastases from other organs within the thyroid. Medullary and papillary carcinoma co-occurrence is the most frequent. Several theories tried to explain the pathogenic mechanisms underlining collision tumors, including the theory which assumes that one tumor predisposes the other, stem cell theory, and random effect theory, but their combination better explains the origin of these tumors. Hypotheses about common genetic behavior responsible for the pathogenesis have also been suggested, such as the involvement of germline mutation of RET (Rearranged during Transfection) proto-oncogene in medullary thyroid carcinoma and papillary thyroid carcinoma coexistence, but there is controversy on this topic. Management of thyroid collision tumors is challenging owing to the presence of two distinct tumors with different biological aggressiveness, treatments options, and prognosis, and needs to be individualized.
甲状腺碰撞瘤是罕见的实体瘤,指的是两种组织学和形态学上不同的肿瘤同时发生,或作为甲状腺内来自其他器官的转移瘤出现。髓样癌和乳头状癌同时出现最为常见。有几种理论试图解释碰撞瘤的致病机制,包括一种肿瘤使另一种肿瘤易患的理论、干细胞理论和随机效应理论,但它们的结合能更好地解释这些肿瘤的起源。也有人提出了关于导致发病机制的共同遗传行为的假说,比如转染重排(RET)原癌基因的种系突变参与甲状腺髓样癌和甲状腺乳头状癌共存,但在这个问题上存在争议。由于存在两种具有不同生物学侵袭性、治疗选择和预后的不同肿瘤,甲状腺碰撞瘤的管理具有挑战性,需要个体化处理。